WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6701 Infant (under 12 months) mortality rate: 662
GDP / capita (US$): 1'6341 Child (under 5 years) mortality rate: 1022

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 16'935  16'460  15'995  15'540  15'095  11'608  8'811  6'823 
Births 693  683  672  662  651  538  419  336 
Surviving infants 645  634  623  612  601  487  374  294 
Pop. less than 5 years 2'983  2'932  2'874  2'804  2'744  2'172  1'663  1'278 
Pop. less than 15 years 7'712  7'530  7'343  7'148  6'972  5'429  4'163  3'110 
Female 15-49 years 3'921  3'801  3'687  3'579  3'468  2'642  1'959  1'539 

Number of reported case

(Click for retrospective incidence data for Burkina Faso)
Diphtheria 725 
Japanese encephalitis
Measles 375  7'362  860  2'511  54'118  6'074  9'804  13'713 
Mumps 8'090 
Pertussis 13  68  351  713  3'888 
Polio* 15  18  145 
Rubella 27  677 
Rubella (CRS)
Tetanus (neonatal) 22  100 
Tetanus (total) 27  74  100  746 
Yellow fever 1'024 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burkina Faso)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS/MICS   83  96  97  99  99  99*  80 
DTP1 2009  94  DHS/MICS   83  94  94  93  93  99*  84 
DTP3 2009  90  DHS/MICS   83  88  90  91  91  99*  57 
HepB_BD         
HepB3          88  90  99*  99*  99* 
Hib3          88  90  99*  99*  99* 
JapEnc         
MCV 2009  87  DHS/MICS   83  82  87  63  63  94  59 
MCV2         
PCV1          31 
PCV3         
Pol3 2009  90  DHS/MICS   83  89  90  90  90  99*  57 
Rota1          31 
Rota_last         
Rubella1         
TT2plus 2009  71  DHS/MICS   83  71  86  82  82  94 
PAB         
VAD1          99*  99*  99* 
YFV 2008  94  EPI   96  100  87  82  82  93  56  65 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burkina Faso)
BCG 96  96  99  99  99  81  95 
DTP1 94  94  93  93  93  97  92 
DTP3 88  90  91  91  92  45  66 
HepB3 88  90  91  91  92 
HepB_BD
Hib3 88  90  91  91  92 
MCV 82  87  89  92  94  48  79 
MCV2
PAB 88  88  88  85  85  57  55 
PCV3
Pol3 89  90  90  90  91  45  66 
Rota_last
YFV 87  87  82  82  93  40 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 10
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 8, 12, 16 weeks; Yes
Measles 9 months; Yes
OPV birth; 8, 12, 16 weeks; Yes
Pneumo_conj 8, 12, 16 weeks; Yes
Rotavirus 8, 12, 16 weeks; Yes
TT 1st contact pregnancy; +1 month; +1, +2, +3 years; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  63  63  63  63  55 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 63  63  63  63  63  63  55 
Nº districts with DTP3 coverage >=80% number 63  63  62  63  63  62 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  98  100  100  98 
Nº districts with measles (MCV1) coverage >=95% number 48  46  43  39  36  49   
% of districts with MCV1 coverage >=95% From 0 to 100% 76  73  68  62  57  78   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 22  39  32  33  30  21  23 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.